Opportunity Information: Apply for RFA TS 09 002
Apply for RFA TS 09 002
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Disease Progression in Persons Exposed to Asbestos Contaminated Vermiculite Ore in Marysville, Ohio (R01)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.161 Health Program for Toxic Substances and Disease Registry.
- This funding opportunity was created on Apr 10, 2009 and posted on Jan 16, 2009.
- Applicants must submit their applications by Mar 16, 2009 Letter of Deadline February 17, 2009. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $500,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $500,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Native American tribal organizations (other than Federally recognized tribal governments) Private institutions of higher education Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) State governments Special district governments County governments City or township governments.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Centers for Disease Control and Prevention (CDC), through its Procurement and Grants Office, released a discretionary grant funding opportunity titled "Disease Progression in Persons Exposed to Asbestos Contaminated Vermiculite Ore in Marysville, Ohio (R01)" under Funding Opportunity Number RFA TS 09 002. The announcement focuses on public health research and is tied to CFDA 93.161, the Health Program for the Agency for Toxic Substances and Disease Registry (ATSDR). The central aim is to study how asbestos-related diseases change over time in a specific group of people: workers in Marysville, Ohio who were exposed to asbestos-contaminated vermiculite ore that originated from Libby, Montana, a site widely associated with amphibole asbestos contamination and long-term health impacts.
The purpose of the grant is to assess and evaluate disease progression in this defined cohort, meaning the funded project is expected to go beyond identifying whether disease exists and instead examine how conditions evolve, worsen, or present new complications over time in exposed individuals. In practical terms, this kind of research typically involves systematic follow-up of participants, comparison of clinical findings across timepoints, and careful evaluation of asbestos-related outcomes such as pleural changes, asbestosis, reduced lung function, and other respiratory or potentially malignancy-related indicators associated with asbestos exposure. The emphasis on a Marysville worker cohort suggests the CDC wanted a targeted investigation tied to a known exposure pathway: vermiculite ore contaminated with asbestos fibers, with Marysville workers representing a population with documented or strongly suspected occupational exposure.
Funding for the opportunity was relatively focused and limited to a single award, with an expected one recipient. The estimated total funding available for fiscal year 2009 was approximately $500,000, and the award ceiling was also $500,000, indicating the CDC anticipated one project funded at or near that amount rather than multiple smaller projects. There was no cost sharing or matching requirement, which generally lowers barriers for applicants by not requiring them to provide additional non-federal dollars to receive the award.
The eligible applicant pool was broad across government and academic sectors and included state governments, county governments, city or township governments, special district governments, and both public and state-controlled institutions of higher education as well as private institutions of higher education. Tribal eligibility was also included, covering federally recognized tribal governments and other Native American tribal organizations. This eligibility structure suggests the CDC anticipated proposals from public health agencies, academic research centers, or partnerships capable of conducting cohort-based health investigations, managing human subjects protections, and implementing longitudinal clinical or epidemiologic assessment.
Key dates associated with the solicitation show it was posted on January 16, 2009, with a letter of intent deadline of February 17, 2009, and an application closing date of March 16, 2009. The announcement lists an estimated funding date of August 31, 2009, implying an anticipated timeline of review, award processing, and project initiation later in the fiscal year. The record indicates creation or update activity on April 10, 2009, and an archive date of April 15, 2009, which typically reflects the administrative lifecycle of the listing once the competition period has concluded.
For applicants or interested parties seeking the full program requirements and application instructions, the CDC directed readers to the full announcement posted on its funding opportunity page. For assistance accessing the announcement electronically, the point of contact provided was the CDC PGOTIMS (Technical Information Management Section) at 770-488-2700.
Frequently Asked Questions (FAQs)
What is the title of this CDC grant opportunity?
The funding opportunity is titled "Disease Progression in Persons Exposed to Asbestos Contaminated Vermiculite Ore in Marysville, Ohio (R01)."
What is the Funding Opportunity Number (FON)?
The Funding Opportunity Number is RFA TS 09 002.
Which federal agency is offering this grant?
The grant was released by the Centers for Disease Control and Prevention (CDC) through its Procurement and Grants Office.
Is this opportunity connected to a specific CFDA program?
Yes. The announcement is tied to CFDA 93.161, the Health Program for the Agency for Toxic Substances and Disease Registry (ATSDR).
What is the main purpose of the grant?
The purpose is to assess and evaluate disease progression over time in a defined cohort of people exposed to asbestos-contaminated vermiculite ore in Marysville, Ohio.
Who is the specific population of interest for this research?
The focus is on workers in Marysville, Ohio who were exposed to asbestos-contaminated vermiculite ore that originated from Libby, Montana.
Why is Libby, Montana mentioned in the announcement?
Libby, Montana is widely associated with amphibole asbestos contamination and long-term health impacts. The Marysville exposure pathway is linked to vermiculite ore sourced from Libby.
What does "disease progression" mean in the context of this grant?
It means the project is expected to go beyond identifying whether disease exists and instead examine how asbestos-related conditions evolve over time, including whether they worsen or develop new complications.
What types of health outcomes does the announcement highlight as relevant?
The opportunity emphasizes asbestos-related outcomes such as pleural changes, asbestosis, reduced lung function, and other respiratory or potentially malignancy-related indicators associated with asbestos exposure.
What kind of study approach is implied by the grant description?
Based on the emphasis on progression over time, the description points toward systematic follow-up of participants, comparison of clinical findings across multiple timepoints, and careful longitudinal evaluation of asbestos-related outcomes.
Is this a broad national study or a targeted cohort investigation?
It is targeted. The announcement centers on a defined cohort of Marysville workers with documented or strongly suspected occupational exposure tied to asbestos-contaminated vermiculite ore.
How many awards was CDC expecting to make?
The opportunity was relatively focused and expected a single award, with one recipient.
How much funding was available for fiscal year 2009?
The estimated total funding available for FY 2009 was approximately $500,000.
What was the award ceiling for this opportunity?
The award ceiling was $500,000, indicating CDC anticipated one project funded at or near that amount.
Was cost sharing or matching required?
No. The announcement states there was no cost sharing or matching requirement.
Which types of applicants were eligible to apply?
Eligibility included state governments, county governments, city or township governments, special district governments, public and state-controlled institutions of higher education, private institutions of higher education, federally recognized tribal governments, and other Native American tribal organizations.
Does the eligibility list suggest the kind of organizations CDC expected to apply?
Yes. The eligible applicant pool suggests CDC anticipated proposals from public health agencies, academic research centers, or partnerships capable of conducting cohort-based investigations and managing the requirements associated with human subjects research and longitudinal clinical or epidemiologic assessment.
When was the opportunity posted?
The solicitation was posted on January 16, 2009.
Was a letter of intent requested, and when was it due?
Yes. The letter of intent deadline was February 17, 2009.
When was the application due?
The application closing date was March 16, 2009.
When was funding expected to be awarded?
The announcement listed an estimated funding date of August 31, 2009.
What do the archive and update dates indicate?
The record indicates creation or update activity on April 10, 2009, and an archive date of April 15, 2009, which typically reflects the administrative lifecycle of the listing once the competition period has concluded.
Where were applicants directed to find full requirements and instructions?
Applicants were directed to the full announcement posted on the CDC funding opportunity page for complete program requirements and application instructions.
Who can be contacted for help accessing the announcement electronically?
The point of contact listed for assistance accessing the announcement electronically was CDC PGOTIMS (Technical Information Management Section) at 770-488-2700.
Browse more opportunities from the same category: Health
Next opportunity: Learn and Serve America School Based Competitive FY 2009
Previous opportunity: Agricultural Water Enhancement Program
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA TS 09 002
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA TS 09 002) also looked into and applied for these:
| Funding Opportunity |
|---|
| Poison Center Support and Enhancement Grant Program Apply for HRSA 09 212 Funding Number: HRSA 09 212 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Part C CAPACITY DEVELOPMENT Apply for HRSA 09 129 Funding Number: HRSA 09 129 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Claude D. Pepper Older Americans Independence Centers (OAICs)(P30) Apply for RFA AG 10 003 Funding Number: RFA AG 10 003 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Structural Analyses of the Ligand Binding Properties of Taste and Smell Receptors (R21) Apply for PA 09 082 Funding Number: PA 09 082 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Program to Expand State Public Health Laboratory Capacity for Newborn Bloodspot Screening (U01) Apply for RFA EH 09 002 Funding Number: RFA EH 09 002 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $500,000 |
| Program to Enhance State Public Health Laboratory Capacity for Newborn Bloodspot Screening (U01) Apply for RFA EH 09 003 Funding Number: RFA EH 09 003 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $150,000 |
| Expanding the Chemical Space for Carbohydrates (R01) Apply for RFA GM 09 005 Funding Number: RFA GM 09 005 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Mechanism of Alcohol Induced Organ Damage (R01) Apply for RFA AA 09 006 Funding Number: RFA AA 09 006 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Medical Monitoring Project (MMP) Apply for CDC RFA PS09 937 Funding Number: CDC RFA PS09 937 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $930,000 |
| EMSC Network Development Demonstration Project (NDDP) Central Data Management and Coordinating Center (CDMCC) Apply for HRSA 09 152 Funding Number: HRSA 09 152 Agency: Health Resources and Services Administration Category: Health Funding Amount: $1,600,000 |
| The NEI Mentored Clinical Scientist Development Program Award (K12) Apply for PAR 09 083 Funding Number: PAR 09 083 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Accelerating Development of Methods for the Study of Complex Patients (R21) Apply for RFA HS 09 002 Funding Number: RFA HS 09 002 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: $300,000 |
| Mentored Clinical Scientist Research Career Development Award (K08) Apply for PAR 09 085 Funding Number: PAR 09 085 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: Case Dependent |
| Independent Scientist Award (K02) Apply for PAR 09 086 Funding Number: PAR 09 086 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: Case Dependent |
| Mentored Research Scientist Research Career Development Award (K01) Apply for PAR 09 087 Funding Number: PAR 09 087 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: Case Dependent |
| Dietary Supplement Research Centers Botanicals (P50) Apply for RFA OD 09 001 Funding Number: RFA OD 09 001 Agency: National Institutes of Health Category: Health Funding Amount: $1,000,000 |
| Tools to Mitigate and Understand the Mental Health Effects of National Disasters SBIR R43/R44 Apply for PA 06 335 Funding Number: PA 06 335 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Tools to Mitigate and Understand the Mental Health Effects of National Disasters STTR R41/R42 Apply for PA 06 336 Funding Number: PA 06 336 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Novel Tools for Investigating Brain derived GPCRs in Mental Health Research (STTR R41/R42) Apply for PA 06 374 Funding Number: PA 06 374 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Novel Tools for Investigating Brain derived GPCRs in Mental Health Research (SBIR R43/R44) Apply for PA 06 375 Funding Number: PA 06 375 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA TS 09 002", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.